Trial Profile
Phase II trial of Trastuzumab in combination with Abraxane for patients with HER2-positive metastatic breast cancer
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 24 Aug 2018
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Trastuzumab (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 05 Jan 2018 Status changed from recruiting to active, no longer recruiting.
- 16 Aug 2011 New trial record